XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' (Deficit) Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Redeemable Convertible Preferred Stock
Beginning Balance at Dec. 31, 2019 $ (201,104) $ 73 $ 1,851 $ 16 $ (203,044)  
Beginning Balance, Shares at Dec. 31, 2019   7,326,185        
Redeemable convertible preferred stock, Beginning Balance at Dec. 31, 2019           $ 302,049
Redeemable convertible preferred stock, Beginning Balance, Shares at Dec. 31, 2019           130,616,784
Accretion of redeemable convertible preferred stock to redemption value           $ 1,277
Accretion of redeemable convertible preferred stock to redemption value (1,277)   (1,277)      
Conversion of preferred stock to common stock upon closing of initial public offering           $ (303,326)
Conversion of preferred stock to common stock upon closing of initial public offering, Shares           (130,616,784)
Conversion of preferred stock to common stock upon closing of initial public offering 303,326 $ 291 303,035      
Conversion of preferred stock to common stock upon closing of initial public offering, Shares   29,127,523        
Issuance of common stock from initial public offering/private placement/At-the-Market offering, net of issuance costs 188,323 $ 122 188,201      
Issuance of common stock from initial public offering/private placement/At-the-Market offering, net of issuance costs, Shares   12,176,471        
Vesting of restricted common stock   $ 4 (4)      
Vesting of restricted common stock, Shares   387,866        
Stock-based compensation 2,792   2,792      
Exercise of common stock options 152 $ 1 151      
Exercise of common stock options, Shares   59,305        
Other comprehensive income (loss) (360)     (360)    
Net loss (30,458)       (30,458)  
Ending Balance at Mar. 31, 2020 261,394 $ 491 494,749 (344) (233,502)  
Ending Balance, Shares at Mar. 31, 2020   49,077,350        
Beginning Balance at Dec. 31, 2019 (201,104) $ 73 1,851 16 (203,044)  
Beginning Balance, Shares at Dec. 31, 2019   7,326,185        
Redeemable convertible preferred stock, Beginning Balance at Dec. 31, 2019           $ 302,049
Redeemable convertible preferred stock, Beginning Balance, Shares at Dec. 31, 2019           130,616,784
Net loss (64,676)          
Ending Balance at Jun. 30, 2020 230,822 $ 496 497,873 173 (267,720)  
Ending Balance, Shares at Jun. 30, 2020   49,645,737        
Beginning Balance at Mar. 31, 2020 261,394 $ 491 494,749 (344) (233,502)  
Beginning Balance, Shares at Mar. 31, 2020   49,077,350        
Vesting of restricted common stock   $ 4 (4)      
Vesting of restricted common stock, Shares   387,870        
Stock-based compensation 2,769   2,769      
Exercise of common stock options 360 $ 1 359      
Exercise of common stock options, Shares   180,517        
Other comprehensive income (loss) 517     517    
Net loss (34,218)       (34,218)  
Ending Balance at Jun. 30, 2020 230,822 $ 496 497,873 173 (267,720)  
Ending Balance, Shares at Jun. 30, 2020   49,645,737        
Beginning Balance at Dec. 31, 2020 245,561 $ 573 642,633 (9) (397,636)  
Beginning Balance, Shares at Dec. 31, 2020   57,254,178        
Issuance of common stock from initial public offering/private placement/At-the-Market offering, net of issuance costs 252,005 $ 28 251,977      
Issuance of common stock from initial public offering/private placement/At-the-Market offering, net of issuance costs, Shares   2,795,700        
Issuance of common stock to acquire Guide 120,032 $ 10 120,022      
Issuance of common stock to acquire Guide, Shares   1,087,153        
Vesting of restricted common stock   $ 4 (4)      
Vesting of restricted common stock, Shares   398,804        
Stock-based compensation 4,648   4,648      
Exercise of common stock options 1,758 $ 2 1,756      
Exercise of common stock options, Shares   199,284        
Other comprehensive income (loss) (15)     (15)    
Net loss (201,560)       (201,560)  
Ending Balance at Mar. 31, 2021 422,429 $ 617 1,021,032 (24) (599,196)  
Ending Balance, Shares at Mar. 31, 2021   61,735,119        
Beginning Balance at Dec. 31, 2020 $ 245,561 $ 573 642,633 (9) (397,636)  
Beginning Balance, Shares at Dec. 31, 2020   57,254,178        
Exercise of common stock options, Shares 605,509          
Net loss $ (277,813)          
Ending Balance at Jun. 30, 2021 548,551 $ 645 1,223,324 31 (675,449)  
Ending Balance, Shares at Jun. 30, 2021   64,452,682        
Beginning Balance at Mar. 31, 2021 422,429 $ 617 1,021,032 (24) (599,196)  
Beginning Balance, Shares at Mar. 31, 2021   61,735,119        
Issuance of common stock from initial public offering/private placement/At-the-Market offering, net of issuance costs 157,785 $ 18 157,767      
Issuance of common stock from initial public offering/private placement/At-the-Market offering, net of issuance costs, Shares   1,761,285        
Vesting of restricted common stock   $ 2 (2)      
Vesting of restricted common stock, Shares   200,403        
Issuance of common stock for success payment liability 30,000 $ 4 29,996      
Issuance of common stock for success payment liability, Shares   349,650        
Stock-based compensation 10,452   10,452      
Exercise of common stock options 4,083 $ 4 4,079      
Exercise of common stock options, Shares   406,225        
Other comprehensive income (loss) 55     55    
Net loss (76,253)       (76,253)  
Ending Balance at Jun. 30, 2021 $ 548,551 $ 645 $ 1,223,324 $ 31 $ (675,449)  
Ending Balance, Shares at Jun. 30, 2021   64,452,682